Parkman Healthcare Partners’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,226
Closed -$153K 109
2023
Q4
$153K Sell
10,226
-46,025
-82% -$564K 0.02% 88
2023
Q3
$827K Buy
56,251
+2,276
+4% +$43.8K 0.15% 93
2023
Q2
$1.35M Buy
53,975
+7,998
+17% +$134K 0.23% 84
2023
Q1
$685K Hold
45,977
0.15% 76
2022
Q4
$644K Sell
45,977
-19,787
-30% -$540K 0.17% 76
2022
Q3
$2.08M Buy
65,764
+761
+1% +$31.9K 0.59% 54
2022
Q2
$2.26M Sell
65,003
-43,922
-40% -$2.81M 0.83% 41
2022
Q1
$12.3M Buy
108,925
+11,507
+12% +$1.33M 3.6% 5
2021
Q4
$9.32M Buy
97,418
+5,009
+5% +$451K 2.11% 19
2021
Q3
$8.18M Buy
92,409
+51,000
+123% +$5.02M 2.07% 18
2021
Q2
$5.08M Buy
41,409
+1,287
+3% +$178K 1.11% 35
2021
Q1
$6.39M Buy
40,122
+3,453
+9% +$586K 1.54% 23
2020
Q4
$5.61M Sell
36,669
-3,333
-8% -$599K 1.44% 27
2020
Q3
$7.43M Buy
40,002
+26,002
+186% +$4.26M 1.97% 18
2020
Q2
$1.7M Buy
+14,000
New +$1.42M 0.49% 60

Other funds holding IMUX